Rutledge Fn
Impact in
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Ovarian cancer diagnosis and treatment 8
- Oncology 7
- Cancer Risks and Factors 2
- Cancer Treatment and Pharmacology 2
- Co-authors
- Fletcher Gh (4 shared papers)Wharton Jt (5 shared papers)Smith Jp (3 shared papers)Jones Hw (1 shared paper)L. Copeland (4 shared papers)Luis Delclos (1 shared paper)Brown Tc (1 shared paper)Morrow Cp (1 shared paper)
- Journals
- PubMed (22 papers)
- Partner nations
- United States
In The Last Decade
Rutledge Fn
22 papers receiving 722 citations
Peers
Comparison fields: 5 of 52
- Obstetrics and Gynecology 343
- Reproductive Medicine 280
- Oncology 176
- Surgery 235
- Epidemiology 173
Countries citing papers authored by Rutledge Fn
This map shows the geographic impact of Rutledge Fn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rutledge Fn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rutledge Fn more than expected).
Fields of papers citing papers by Rutledge Fn
This network shows the impact of papers produced by Rutledge Fn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rutledge Fn. The network helps show where Rutledge Fn may publish in the future.
Co-authors
The 14 scholars most cited alongside Rutledge Fn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Preirradiation celiotomy and extended field irradiation for invasive carcinoma of the cervix. | 1977 | 160 |
| 2 | Epithelial carcinoma of the ovary:prognostic importance of histologic grade. | 1975 | 95 |
| 3 | Postoperative treatment of early cancer of the ovary: a random trial between postoperative irradiation and chemotherapy. | 1975 | 75 |
| 4 | Mixed germ cell tumors of the ovary. | 1984 | 57 |
| 5 | Clinical significance of rectal and bladder dose measurements in radium therapy of cancer of the uterine cervix. | 1958 | 57 |
| 6 | PELVIC LYMPHADENECTOMY AS AN ADJUNCT TO RADIATION THERAPY IN TREATMENT FOR CANCER OF THE CERVIX. | 1965 | 56 |
| 7 | Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: role of adjuvant radiotherapy. | 1987 | 50 |
| 8 | Carcinoma of the cervix associated with pregnancy. | 1970 | 48 |
| 9 | Melanoma of the vulva. | 1972 | 34 |
| 10 | Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium. | 1986 | 27 |
| 11 | Second genital primary squamous neoplasms in vulvar carcinoma: viral and histopathologic correlates. | 1993 | 26 |
| 12 | Random study of hexamethylmelamine, 5-fluorouracil, and melphalan in treatment of advanced carcinoma of the ovary. | 1975 | 25 |
| 13 | Policies of treatment in cancer of the cervix uteri. | 1962 | 24 |
| 14 | Leukocyte interferon (IFN alpha) in patients with epithelial ovarian carcinoma. | 1983 | 23 |
| 15 | Immunotherapy for vulvar carcinoma with virus-modified homologous extracts. | 1983 | 13 |
| 16 | Intermittent Iv homoharringtonine for the treatment of refractory epithelial carcinoma of the ovary: a phase II trial. | 1984 | 9 |
| 17 | Clinical evaluation of high-dose cytarabine and cisplatin in recurrent cervical carcinoma. | 1985 | 6 |
| 18 | Chemotherapy in advanced ovarian cancer. | 1975 | 5 |
| 19 | Continuous-infusion vinblastine for treatment of refractory epithelial carcinoma of the ovary: a phase II trial. | 1984 | 4 |
| 20 | The significance of residual tumor after preoperative pelvic irradiation for stage II endometrial carcinoma. | 1987 | 3 |
About Rutledge Fn
Rutledge Fn is a scholar working on Reproductive Medicine, Oncology, Epidemiology, Obstetrics and Gynecology and Surgery, having authored 22 papers that have together received 802 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (7 papers), Cervical Cancer and HPV Research (6 papers), Sarcoma Diagnosis and Treatment (2 papers), Cancer Risks and Factors (2 papers), Cancer Treatment and Pharmacology (2 papers), Multiple and Secondary Primary Cancers (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Obstetrics and Gynecology (343 citations), Reproductive Medicine (280 citations), Oncology (176 citations), Surgery (235 citations) and Epidemiology (173 citations). Rutledge Fn has collaborated with scholars based in United States. Frequent co-authors include Fletcher Gh, Wharton Jt, Smith Jp, Jones Hw, L. Copeland, Luis Delclos, Brown Tc, Morrow Cp, Creasman Wt and D. M. Gershenson. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.